AI Agentic Workflow for Synthetic Data in Counterfactual Treatment Effect Estimation

This workflow directly addresses the prohibitive cost and opacity of validating causal models like doubly robust estimators or instrumental variables on real-world data, where ground truth is unknowable. By automating the creation of synthetic cohorts with pre-defined treatment effects, it provides a controlled, transparent sandbox for econometric teams to benchmark performance, stress-test assumptions, and accelerate method selection. The operational upside comes from reducing validation cycles from months to hours and eliminating the regulatory friction of using sensitive patient records for R&D.

Implementation integrates conditional generative models (e.g., CTGAN, DoppelGANger) with causal graph frameworks like DoWhy or CausalML, orchestrated via LangGraph. The orchestrator agent ingests protocol-defined confounding structures and treatment effect sizes, managing the generation loop and routing outputs to automated test suites. Critical controls include statistical fidelity validation against propensity score distributions, differential privacy checks, and human-in-the-loop review gates for novel effect structures before release to platforms such as Databricks or SAS for researcher consumption.

This workflow eliminates the manual bottleneck of sourcing and curating data for causal inference, where researchers need transparent 'what-if' scenarios to validate methods like propensity score matching or instrumental variables. By automating the generation of cohorts with pre-defined treatment effects, it accelerates method development and benchmarking by 80%, turning a months-long data procurement process into an on-demand service. The operational upside comes from faster, more reliable R&D cycles and reduced dependency on scarce, sensitive real-world data.

Implementation integrates with causal graph frameworks (e.g., DoWhy, CausalML) and econometric testing platforms, using the orchestrator to enforce schema alignment and known effect sizes. The validation agent performs automated statistical checks (e.g., KS tests, covariate balance) and cross-validation against target estimands, routing anomalies for human review. Controls include effect-size guardrails, differential privacy layers, and immutable audit logs for regulatory compliance, ensuring the synthetic data is both useful for science and defensible for governance.

This workflow automates the creation of synthetic patient cohorts with known, embedded treatment effects, directly addressing the prohibitive cost and ethical constraints of running real-world A/B tests in healthcare. It eliminates the manual bottleneck of data procurement and scenario modeling for causal inference research, allowing biostatistics and health economics teams to validate econometric methods like propensity score matching or doubly robust estimation at scale and speed. The operational upside comes from accelerating R&D cycles for comparative effectiveness research and enabling rapid, low-risk experimentation with novel causal graph structures.

Implementation begins with Phase 1, integrating with OMOP or PCORnet CDMs to capture baseline covariate distributions and define the causal graph in frameworks like DoWhy or CausalML. Phase 2 deploys conditional generative models (e.g., CTGAN, TabDDPM) orchestrated by agents that enforce clinical plausibility and embed the pre-specified treatment effect. Phase 3 automates validation by executing the target estimation method on the synthetic cohort and scoring its accuracy in recovering the known effect. The final production phase, built on LangGraph, adds an API gateway for on-demand generation, integrates approval gates for data release, and establishes comprehensive audit logging to meet IRB and internal governance requirements for synthetic data provenance.

This workflow directly addresses the bottleneck of acquiring real-world patient data for validating causal inference methods like propensity score matching or instrumental variable analysis. By automating the generation of synthetic cohorts with embedded treatment effects, research teams can rapidly benchmark models, test sensitivity to unobserved confounding, and refine study designs before costly real-data analysis. The operational upside is a 70-80% reduction in validation cycle time and the elimination of legal and privacy hurdles associated with sharing sensitive patient records for methodological development.

Implementation integrates the LangGraph orchestrator with a conditional generative model (e.g., CTGAN, DoppelGANger) and a causal graph framework like DoWhy or CausalML. The governance agent validates requests against pre-approved IRB protocols and data use agreements, logging all decisions. Synthetic cohorts are generated with known Average Treatment Effects (ATE), then validated by an agent running statistical tests (KS, propensity score distributions) against real-world reference data. The final, approved dataset is delivered to a secure computational sandbox (e.g., a JupyterHub instance) with full lineage recorded in a data catalog like Amundsen or Collibra for auditability.